Avalo Therapeutics (AVTX) Change in Taxes (2017 - 2020)
Avalo Therapeutics' (AVTX) quarterly Change in Taxes came in at $839000.0 in Q2 2020, up 298.73% YoY from $210416.9 in Q3 2019, and up 252.27% on a QoQ basis from -$551000.0 in Q1 2020.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Change in Taxes (2017 - 2020) Analysis & Trends
Avalo Therapeutics (AVTX) has 4 years of Change in Taxes data on file, last reported at $839000.0 in Q2 2020.
- Quarterly Change in Taxes rose 298.73% year-over-year to $839000.0 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was $839000.0 (up 146.25% YoY) and the FY2020 annual result came in at $288000.0, up 119.45% from the prior year.
- Change in Taxes climbed to $839000.0 in Q2 2020, from -$551000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $3.2 million in Q3 2017 to a low of -$970852.0 in Q4 2017.
- A 4-year average of $69972.6 and a median of -$190199.0 in 2018 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2019 — Change in Taxes slumped 3040.65% — and 2020, when it soared 298.73%.
- Tracing AVTX's Change in Taxes over 4 years: stood at -$970852.0 in 2017, then jumped by 83.23% to -$162790.0 in 2018, then sank by 184.28% to -$462783.0 in 2019, then soared by 281.29% to $839000.0 in 2020.
- The last three Change in Taxes figures came in at $839000.0 (Q2 2020), -$551000.0 (Q1 2020), and -$462783.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Avalo Therapeutics | 843.26 Mn | 843.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 839,000.00 |
| Mar 31, 2020 | -551,000.00 |
| Dec 31, 2019 | -462,783.00 |
| Sep 30, 2019 | -378,020.00 |
| Jun 30, 2019 | -422,176.00 |
| Mar 31, 2019 | -217,608.00 |
| Dec 31, 2018 | -162,790.00 |
| Sep 30, 2018 | 24,000.00 |
| Jun 30, 2018 | -95,500.00 |
| Mar 31, 2018 | 7,400.00 |
| Dec 31, 2017 | -970,852.00 |
| Sep 30, 2017 | 3.23 Mn |